BEUDAMED
    FDA Adverse Event Injury Summary report: N

    EUFLEXXA 10 MG/ML 2 ML (6=3SYR)

    MDR report key: 14593615 · Received June 2, 2022

    Report

    Report Number
    MW5110090
    Event Type
    Injury
    Date Received
    June 2, 2022
    Date of Event
    March 1, 2022
    Report Date
    June 1, 2022
    Manufacturer
    FERRING PHARMACEUTICALS INC.
    Product Code
    MOZ
    UDI-DI
    5556641001
    Adverse Event
    Yes
    Report Source
    Voluntary report
    Reporter Location
    PA, US
    Reporter Occupation
    PHARMACIST
    Health Professional
    Yes

    Narratives

    Description of Event or Problem · 0

    PT'S WIFE (B)(6) REPORTS PT WAS DIAGNOSED WITH PROSTATE CANCER (B)(6) 2022. INJECT 1 SYRINGE INTRA-ARTICULARLY TO RIGHT KNEE EVERY WEEK FOR 3 WEEKS.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    2161557 EUFLEXXA 10 MG/ML 2 ML (6=3SYR) ACID, HYALURONIC, INTRAARTICULAR MOZ FERRING PHARMACEUTICALS INC. T10886A 5556641001
    2161558 EUFLEXXA 10 MG/ML 2 ML (6=3SYR) ACID, HYALURONIC, INTRAARTICULAR MOZ FERRING PHARMACEUTICALS INC.
    2161559 EUFLEXXA 10 MG/ML 2 ML (6=3SYR) ACID, HYALURONIC, INTRAARTICULAR MOZ FERRING PHARMACEUTICALS INC.

    Patients

    Seq Age Sex Outcome Treatment
    1 76 YR Male FLOMAX CAP 0.4 MG| LABETALOL TAB 200 MG| METFORMIN TAB 500 MG| MIRTAZAPINE TAB 15 MG| PREDNISONE TAB 5 MG